Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up

M. Špiritović, B. Heřmánková, S. Oreská, H. Štorkánová, O. Růžičková, L. Vernerová, M. Klein, K. Kubínová, H. Šmucrová, A. Rathouská, P. Česák, M. Komarc, V. Bunc, K. Pavelka, L. Šenolt, H. Mann, J. Vencovský, M. Tomčík

. 2021 ; 23 (1) : 173. [pub] 20210621

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NV16-33542A MZ0 CEP Register
NV16-33542A MZ0 CEP Register

BACKGROUND: The structural and functional changes of the skeletal muscles in idiopathic inflammatory myopathies (IIM) caused by inflammation and immune changes can be severely disabling. The objective of this study was to assess the effect of a 24-week program combining a supervised training of activities of daily living (ADL), resistance, and stability with home exercise for improving muscle function, compared to a daily home-based exercise representing the regular outpatient care. METHODS: Fifty-seven patients with IIM were consecutively and non-selectively enrolled in an intervention (IG, n = 30) or control (CG, n = 27) group. Both groups were provided a standard-of-care pharmacological treatment and follow-up. Only the IG underwent the supervised intervention twice a week for 1 h per session. At baseline, 12, 24, and 48 weeks, all patients were assessed by an assessor blinded to the intervention for primary outcomes: muscle strength (Manual Muscle Testing of eight muscle groups [MMT-8]) and endurance (Functional Index-2 [FI-2]), and secondary outcomes: stability and body composition. Secondary outcomes also included questionnaires evaluating disability (Health Assessment Questionnaire [HAQ]), quality of life (Short Form 36 [SF-36]), depression (Beck's Depression Inventory-II [BDI-II]), and fatigue (Fatigue Impact Scale [FIS]), and analysis of the systemic and local inflammatory response and perceived exertion to assess the safety of the intervention. RESULTS: Twenty-seven patients in the IG and 23 in the CG completed the entire program and follow-up. At week 24, compared to deterioration in the CG, we found a significant improvement in the IG in muscle strength (mean % improvement compared to baseline by 26%), endurance (135%), disability (39%), depression (26%), stability (11%), and basal metabolism (2%) and a stabilization of fitness for physical exercise. The improvement was clinically meaningful (a 24-week change by >20%) in most outcomes in a substantial proportion of patients. Although the improvement was still present at 48 weeks, the effect was not sustained during follow-up. No significant increase in the systemic or local expression of inflammatory markers was found throughout the intervention. CONCLUSIONS: This 24-week supervised intervention focused on ADL training proved to be safe and effective. It not only prevented the progressive deterioration, but also resulted in a significant improvement in muscle strength, endurance, stability, and disability, which was clinically meaningful in a substantial proportion of patients. TRIAL REGISTRATION: ISRCTN35925199 (retrospectively registered on 22 May 2020).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018446
003      
CZ-PrNML
005      
20230801151537.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13075-021-02544-5 $2 doi
035    __
$a (PubMed)34154634
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Špiritović, Maja $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
245    14
$a The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up / $c M. Špiritović, B. Heřmánková, S. Oreská, H. Štorkánová, O. Růžičková, L. Vernerová, M. Klein, K. Kubínová, H. Šmucrová, A. Rathouská, P. Česák, M. Komarc, V. Bunc, K. Pavelka, L. Šenolt, H. Mann, J. Vencovský, M. Tomčík
520    9_
$a BACKGROUND: The structural and functional changes of the skeletal muscles in idiopathic inflammatory myopathies (IIM) caused by inflammation and immune changes can be severely disabling. The objective of this study was to assess the effect of a 24-week program combining a supervised training of activities of daily living (ADL), resistance, and stability with home exercise for improving muscle function, compared to a daily home-based exercise representing the regular outpatient care. METHODS: Fifty-seven patients with IIM were consecutively and non-selectively enrolled in an intervention (IG, n = 30) or control (CG, n = 27) group. Both groups were provided a standard-of-care pharmacological treatment and follow-up. Only the IG underwent the supervised intervention twice a week for 1 h per session. At baseline, 12, 24, and 48 weeks, all patients were assessed by an assessor blinded to the intervention for primary outcomes: muscle strength (Manual Muscle Testing of eight muscle groups [MMT-8]) and endurance (Functional Index-2 [FI-2]), and secondary outcomes: stability and body composition. Secondary outcomes also included questionnaires evaluating disability (Health Assessment Questionnaire [HAQ]), quality of life (Short Form 36 [SF-36]), depression (Beck's Depression Inventory-II [BDI-II]), and fatigue (Fatigue Impact Scale [FIS]), and analysis of the systemic and local inflammatory response and perceived exertion to assess the safety of the intervention. RESULTS: Twenty-seven patients in the IG and 23 in the CG completed the entire program and follow-up. At week 24, compared to deterioration in the CG, we found a significant improvement in the IG in muscle strength (mean % improvement compared to baseline by 26%), endurance (135%), disability (39%), depression (26%), stability (11%), and basal metabolism (2%) and a stabilization of fitness for physical exercise. The improvement was clinically meaningful (a 24-week change by >20%) in most outcomes in a substantial proportion of patients. Although the improvement was still present at 48 weeks, the effect was not sustained during follow-up. No significant increase in the systemic or local expression of inflammatory markers was found throughout the intervention. CONCLUSIONS: This 24-week supervised intervention focused on ADL training proved to be safe and effective. It not only prevented the progressive deterioration, but also resulted in a significant improvement in muscle strength, endurance, stability, and disability, which was clinically meaningful in a substantial proportion of patients. TRIAL REGISTRATION: ISRCTN35925199 (retrospectively registered on 22 May 2020).
650    12
$a činnosti denního života $7 D000203
650    _2
$a terapie cvičením $7 D005081
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a svalová síla $7 D053580
650    _2
$a kosterní svaly $7 D018482
650    12
$a myozitida $7 D009220
650    _2
$a kvalita života $7 D011788
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Heřmánková, Barbora $u Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
700    1_
$a Oreská, Sabína $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Štorkánová, Hana $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Růžičková, Olga $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vernerová, Lucia $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic
700    1_
$a Klein, Martin $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kubínová, Kateřina $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Šmucrová, Hana $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic
700    1_
$a Rathouská, Adéla $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic
700    1_
$a Česák, Petr $u Department of Human Movement Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic $7 xx0228034
700    1_
$a Komarc, Martin $u Department of Methodology, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
700    1_
$a Bunc, Václav $u Department of Human Movement Laboratory, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
700    1_
$a Pavelka, Karel $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Šenolt, Ladislav $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Mann, Heřman $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vencovský, Jiří $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tomčík, Michal $u Institute of Rheumatology, Na Slupi 4, 128 00, Prague 2, Czech Republic. michaltomcik@yahoo.com $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. michaltomcik@yahoo.com
773    0_
$w MED00007534 $t Arthritis research & therapy $x 1478-6362 $g Roč. 23, č. 1 (2021), s. 173
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34154634 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20230801151534 $b ABA008
999    __
$a ok $b bmc $g 1689525 $s 1138890
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 23 $c 1 $d 173 $e 20210621 $i 1478-6362 $m Arthritis research & therapy $n Arthritis Res Ther $x MED00007534
GRA    __
$a NV16-33574A $p MZ0 $a NV16-33542A $p MZ0
GRA    __
$a NV16-33574A $p MZ0 $a NV16-33542A $p MZ0
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...